Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy
Condition(s):Effects of ImmunotherapyLast Updated:March 26, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Effects of ImmunotherapyLast Updated:March 26, 2021Not yet recruiting
Condition(s):Immunotherapy; Lung CancerLast Updated:February 27, 2020Recruiting
Condition(s):EphA2 Positive Malignant Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):Unexplained Recurrent Miscarriage and Recurrent Implantation FailureLast Updated:April 11, 2018Completed
Condition(s):Rhinitis, Allergic, SeasonalLast Updated:November 15, 2013Completed
Condition(s):Urinary Bladder NeoplasmLast Updated:January 11, 2018Unknown status
Condition(s):GD2 Positive Glioma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):GPC3 Positive Hepatocellular Carcinoma; CAR-T Cell ImmunotherapyLast Updated:July 16, 2020Withdrawn
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 19, 2018Unknown status
Condition(s):Allergy to Shrimp; ImmunotherapyLast Updated:September 17, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.